A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits

Biopharmaceutics and Drug Disposition

Volumn 17, Issue 6, 1996, Pages 493-499

  Hu, Oliver Yoa Pu ^a   Wu, Chih Yuan ^b   Chan, Win Kai ^b   Wu, Felicia Y H ^b   Whang Peng, Jacqueline ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

menadiol sodium diphosphate (synkayvite); menadione; pharmacokinetics

Indexed keywords

ANTINEOPLASTIC AGENT; MENADIONE;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG ERYTHROCYTE LEVEL; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHARMACOKINETICS; RABBIT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; HEMOSTATICS; INJECTIONS, INTRAVENOUS; RABBITS; SPECTROPHOTOMETRY, ULTRAVIOLET; VITAMIN K;

EID: 0029795201     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199608)17:6<493::AID-BDD972>3.0.CO;2-6     Document Type: Article

References (25)

1. G. O. Lowe and D. H. Lawson, Drug therapy reviews: clinical use of homeostatic agents. Am. J. Hop. Pharm., 35, 414-422 (1978).
2. 3 inhibition of malignant murine cell growth and human tumor colon formation. Cancer Treat. Rep., 69, 527-532 (1985).
3. 3 (menadione) inhibits the growth of mammalian tumor cells in culture. Life Sci 29, 1189-1292 (1981).
4. M. P. Uitendal, H. H. W. Thijssen, H. T. H. Vervort and M. H. J. Drittij, Potentiation of cytotoxicity of coumarin derivatives from B16 cells by vitamin K. Anticancer Res., 5, 619-620 (1985).
5. G. Powis, B. A. Svigen and P. Appel, Quinone stimulated superoxide formation by subcellular fraction, isolated hepatocytes and other cells. Mol. Pharmacol., 20, 387-394 (1981).
6. C. Lind, P. Hovhetein and L. Ernster, DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and speroxide radical formation. Arch. Biochem. Biophys., 216, 178-185 (1982).
7. E. J. Meredith and D. J. Reed, Depletion in vitro of mitochondrial glutathion in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol., 32, 1383-1388 (1983).
8. 3 and related quinones, like tumor promoting phorbol esters, alter the affinity of epidermal growth factor for its membrane receptors. J. Biol. Chem., 248, 8735-8739 (1980).
9. N. Takakashi, J. Schreiber, V. Fisher and R. P. Mason, Formation of glutathion-conjugated semiquinones by the reaction of quinone with glutathione: an ESR study. Arch. Biochem. Biophys., 252, 41-48 (1987).
10. T. Akerboom, T. Bultmann and H. Sies, Inhibition of taurocholate excretion during menadione metabolism in the perfused rat liver. Arch. Biochem. Biophys., 263, 10-18 (1988).
11. K. Ojajima, M. Inoue, K. Itoh, S. Hoviuchi and Y. Morino, Interorgan cooperation in enzymatic processing and membrane transport of glutathione-S-conjugate. In Glutathione Storage, Transport, and Turnover in Mammals, Y. Sakamoto, T. Higashi and N. Tateishi (Eds), Japan Scientific Societies, Tokyo, 1980, pp. 129-144.
12. H. Thor, M. T. Smith, P. Hartzell, G. Bellomo, S. A. Jewell and S. Orrenius, The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implication of oxidative stress in intact cells. J. Biol. Chem., 257, 12419-12425 (1982).
13. R. T. Chlebowski, S. Akman and T. B. Block, Vitamin K in the treatment of cancer, Cancer Treat. Rev., 12, 49-63 (1985).
14. P. P. Dendy, Further studies on the uptake of Synkavite and a radioactive analog into tumor cells in tissue culture. Br. J. Cancer, 24, 817-825 (1970).
15. M. J. Thierry and J. W. Suttie, Distribution and metabolism of menadiol diphosphate in the rat. J. Nutr., 97, 512-516 (1969).
16. Y. Z. Su, T. E. Duarte, P. L. Dill and L. M. Weisenthal, Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms. Cancer Treat. Rep., 71, 619-625 (1987).
17. R. Losito, C. A. Owen Jr. and E. V. Fluck, Metabolism of [C14] menadione. Biochemistry, 6, 62-68 (1967).
18. W. V. Taggart and J. T. Matschiner, Metabolism of menadione-6, 7-3H in the rat. Biochemistry, 8, 1141-1146 (1969).
19. S. A. Akman, F. Kusu, K. Takamura, R. Chlebowski and J. Block, Differential pulse polarographic determination of plasma menadione. Anal. Biochem., 141, 488-493 (1984).
20. 3 in plasma and its application in pharmacokinetic study. J. Chromatogr., 666, 299-305 (1995).
21. C. M. Metzler and D. L. Weiner, PCNONLIN User's Guide, Statistical Consultants, Lexington, KY, 1986.
22. K. Yamaoka, T. Nakagawa and T. Uno, Application of Akaike's information criterion (AIC) in the evalvation of linear pharmacokinetic equations. J. Pharm. Biopharm., 6, 165-175 (1978).
23. A. J. Sedman and J. G. Wagner, CSTRIP, a FORTANIV computer program for obtaining initial polyexponential parameter estimates. J. Pharm. Sci., 65, 1006-1010 (1976).
24. M. Gibaldi and D. Perrier, Pharmacokinetics, 2nd edn, Dekker, New York, 1982, pp. 63-80.
25. S. A. Akman, B. Carr, L. Leong, K. Margolin, O. Odujintin and J. Doroshow, Phase I trial of menadiol sodium diphosphate (Synkayvite) in advanced cancer. Proc. Am. Soc. Clin. Oncol., 7, 76 (1988).